Randomized Controlled Trial to Evaluate Feasibility and Safety of Granulocyte Colony-Stimulating Factor Treatment in Patients with Acute Myocardial Infarctio
Not Applicable
- Conditions
- Acute Myocardial Infarction
- Registration Number
- JPRN-C000000152
- Lead Sponsor
- Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
previous MI persistent severe heart failure uncontrolled myocardial ischemia malignant disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method changes between global LVEF,LVESV and LVEDV at baseline and those after 6 months follow-up
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms by which G-CSF promotes myocardial repair in acute myocardial infarction patients?
How does G-CSF treatment compare to standard reperfusion therapies in AMI clinical outcomes?
Which biomarkers correlate with successful G-CSF mobilization of cardiac progenitor cells in STEMI patients?
What adverse events are associated with G-CSF administration post-MI and how are they managed?
Are there synergistic effects when combining G-CSF with stem cell therapies for myocardial regeneration?